Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin

Adv Exp Med Biol. 1992:326:307-17. doi: 10.1007/978-1-4615-3030-5_37.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colorectal Neoplasms / pathology
  • Doxorubicin / administration & dosage*
  • Doxorubicin / adverse effects
  • Doxorubicin / pharmacokinetics
  • Drug Carriers
  • Erythrocyte Membrane / drug effects*
  • Glutaral*
  • Humans
  • In Vitro Techniques
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / secondary
  • Male
  • Middle Aged
  • Sodium Pertechnetate Tc 99m

Substances

  • Drug Carriers
  • Doxorubicin
  • Sodium Pertechnetate Tc 99m
  • Glutaral